The document discusses the challenges clinical research associates (CRAs) face due to increasing data and system complexity in clinical trials. It notes CRAs now have to work with many different tools and systems, undermining clarity, focus and efficiency. The document argues electronic data capture (EDC) systems need modern requirements like providing a holistic site view across studies, ensuring compliance with monitoring plans, enabling agility to adapt plans, and helping CRAs focus on critical data by removing non-essential information and noise. It provides examples of how analytics and metrics could help measure monitoring performance and efficiency.
eCOA and ePRO and Their Use in Clinical Trials_pptxClinosolIndia
Virtual clinical trials are becoming even more popular because of technology advances. They offer enormous benefits to sponsors and patients. However, there are challenges. One of the key elements of a virtual clinical trial is ePRO and eCOA.
Patient-reported outcome (PRO) endpoints are often necessary to adequately evaluate the treatment benefit provided by new medical products (e.g., drugs) in clinical trials.
The movement from paper-based to electronic PRO (ePRO) data collection has enhanced the integrity and accuracy of PRO data in clinical trials.
The US Food and Drug Administration has made it clear that electronic capture of clinical trial source data is preferred over paper-based data collection.
Efficient Trial Management through Unified CTMS and Study Start-upVeeva Systems
Learn the benefits of a unified clinical landscape, particularly how clinical trial management software (CTMS) and study start-up applications lead to more efficient trial management when working in concert with one another.
Difference between Monitoring and AuditingClinosolIndia
Monitoring
On-going process usually directed by management to ensure processes are working as intended.
Auditing
A formal, systematic, and disciplined approach designed to evaluate and improve the effectiveness of processes and related controls.
Assures quality of trails.
Auditing is governed by professional standards, completed by individuals independent of the process being audited, and normally performed by individuals with one of several acknowledged certifications.
Objectivity in governance reporting is the benefit of independence
Data integrity - Regulatory Perspective and Challenges: santoshnarla
Data Integrity: Regulatory Perspective and Challenges.
This presentation will present the importance of data integrity in the pharma industry with regards to the quality compliance and its impact on industry. This presentation also emphasizes on importance of regulatory affairs department in ensuring the data integrity and regulatory challenges.
Performance metrics are an essential element of the management review process.
Quality metrics may include elements such as customer satisfaction, supplier performance, manufacturing defects, complaints, cycle times and many other internal or external processes.
This presentation provides a framework for establishing right quality indicators for evaluating the performance of the quality system.
Clinical Trial Management System Implementation GuidePerficient, Inc.
Clinical trials account for the majority of the cost in new drug development – a cost that is
constantly increasing. Not only are clinical trials expensive, but they are lengthy, complex
and highly scrutinized. Technology solutions play a significant role in helping life sciences
organizations oversee these critical tasks.
In this slideshare, we discuss:
1. Signs that a CTMS is needed
2. Benefits of a CTMS
3. Preparing to explore CTMS options
4. Developing a CTMS selection checklist
5. Choosing an implementation partner
6. Considering post-implementation support
An introduction to Life Sciences Computer System Validation, applicable regulation, SDLC phases, software categorisation, risk/ change/ deviation management, validation deliverable, risk based approach, regulatory inspection, audit findings, causes of compliance failure, key concepts in CSV etc.
eCOA and ePRO and Their Use in Clinical Trials_pptxClinosolIndia
Virtual clinical trials are becoming even more popular because of technology advances. They offer enormous benefits to sponsors and patients. However, there are challenges. One of the key elements of a virtual clinical trial is ePRO and eCOA.
Patient-reported outcome (PRO) endpoints are often necessary to adequately evaluate the treatment benefit provided by new medical products (e.g., drugs) in clinical trials.
The movement from paper-based to electronic PRO (ePRO) data collection has enhanced the integrity and accuracy of PRO data in clinical trials.
The US Food and Drug Administration has made it clear that electronic capture of clinical trial source data is preferred over paper-based data collection.
Efficient Trial Management through Unified CTMS and Study Start-upVeeva Systems
Learn the benefits of a unified clinical landscape, particularly how clinical trial management software (CTMS) and study start-up applications lead to more efficient trial management when working in concert with one another.
Difference between Monitoring and AuditingClinosolIndia
Monitoring
On-going process usually directed by management to ensure processes are working as intended.
Auditing
A formal, systematic, and disciplined approach designed to evaluate and improve the effectiveness of processes and related controls.
Assures quality of trails.
Auditing is governed by professional standards, completed by individuals independent of the process being audited, and normally performed by individuals with one of several acknowledged certifications.
Objectivity in governance reporting is the benefit of independence
Data integrity - Regulatory Perspective and Challenges: santoshnarla
Data Integrity: Regulatory Perspective and Challenges.
This presentation will present the importance of data integrity in the pharma industry with regards to the quality compliance and its impact on industry. This presentation also emphasizes on importance of regulatory affairs department in ensuring the data integrity and regulatory challenges.
Performance metrics are an essential element of the management review process.
Quality metrics may include elements such as customer satisfaction, supplier performance, manufacturing defects, complaints, cycle times and many other internal or external processes.
This presentation provides a framework for establishing right quality indicators for evaluating the performance of the quality system.
Clinical Trial Management System Implementation GuidePerficient, Inc.
Clinical trials account for the majority of the cost in new drug development – a cost that is
constantly increasing. Not only are clinical trials expensive, but they are lengthy, complex
and highly scrutinized. Technology solutions play a significant role in helping life sciences
organizations oversee these critical tasks.
In this slideshare, we discuss:
1. Signs that a CTMS is needed
2. Benefits of a CTMS
3. Preparing to explore CTMS options
4. Developing a CTMS selection checklist
5. Choosing an implementation partner
6. Considering post-implementation support
An introduction to Life Sciences Computer System Validation, applicable regulation, SDLC phases, software categorisation, risk/ change/ deviation management, validation deliverable, risk based approach, regulatory inspection, audit findings, causes of compliance failure, key concepts in CSV etc.
Overview on “Computer System Validation” CSVAnil Sharma
HI this is Anil Sharma, Executive Compliance in USV LTD. I want to share my brief knowledge on CSV with you. I hope my presentation will help you to understand basics of CSV.
Data Integrity Issues in Pharmaceutical CompaniesPiyush Tripathi
Data integrity refers to maintaining and assuring the accuracy and consistency of data over its entire life-cycle, and is a critical aspect to the design, implementation and usage of any system which stores, processes, or retrieves data.
Provide recommendations and background information concerning computerised systems
Information will be of assistance to inspectors for training purposes and during the inspection
Where automated systems and electronic records are used in warehouses and similar establishments where GDP requirements are applicable, controls and disciplines outlined in this document, or a best practice alternatives are expected to be in place.
Vertically integrated companies (R&D, manufacturing and distribution) will already apply such controls and compliance measures.
International regulatory agencies have collaborated to produce this guidance.
Intended as a reference for regulated users, including their suppliers, in addition to regulatory inspectors and investigators.
Provides a logical explanation of the basic requirements for the implementation, validation and operation of computerised systems.
May be adapted to identify the criteria for a regulated user, or a regulatory agency, in an inspection of GxP computer systems.
National legislation should to be referred to when determining the extent to which the provisions laid down in this document may be applicable.
This presentation gives a summary of this guidance.
Migrating from Oracle AERS to Argus Safety: Reasons for the MovePerficient, Inc.
Not too long ago, Oracle AERS was the most widely-used adverse event report system. However, with the acquisition of Relsys and its safety and pharmacovigilance system in 2009, Argus Safety quickly became the go-to software for most life sciences companies. Its capabilities and comprehensiveness are unmatched.
Companies currently using Oracle AERS have expressed interest in moving to Argus Safety, but want to know more before making the jump. This webinar is meant to do just that – answer your common questions.
Please join Perficient's Dr. Rodney Lemery, director of safety and pharmacovigilance, as he will:
Compare Argus Safety to AERS
Cover the options of effectively migrating to Argus Safety
CRO/Vendor oversight should support sponsor regulatory requirements and cost containment.Quality Management in clinical operations are Centralized Monitoring, Study Quality Metrics and CRO Oversight.
The PV audit ensures that a company’s drug safety and pharmacovigilance operations comply with applicable laws, regulations and guidances worldwide, and compare to best practices for organizations of similar size.
Using Vault eTMF Milestones and EDLs to Support Inspection ReadinessVeeva Systems
Hear how Daiichi Sankyo is using milestones and expected document lists (EDLs) to enable ongoing inspection readiness and proactive TMF management and oversight.
A session wise PPT for Big Data with knowledge check. The PPT outlines the meaning and purpose of structured, semi-structured, non-structured data. Plus, the PPT discusses about the need and evolution of Big Data as well as its applications. Scope of professional opportunities and skills required are also outlined in the PPT.
Overview on “Computer System Validation” CSVAnil Sharma
HI this is Anil Sharma, Executive Compliance in USV LTD. I want to share my brief knowledge on CSV with you. I hope my presentation will help you to understand basics of CSV.
Data Integrity Issues in Pharmaceutical CompaniesPiyush Tripathi
Data integrity refers to maintaining and assuring the accuracy and consistency of data over its entire life-cycle, and is a critical aspect to the design, implementation and usage of any system which stores, processes, or retrieves data.
Provide recommendations and background information concerning computerised systems
Information will be of assistance to inspectors for training purposes and during the inspection
Where automated systems and electronic records are used in warehouses and similar establishments where GDP requirements are applicable, controls and disciplines outlined in this document, or a best practice alternatives are expected to be in place.
Vertically integrated companies (R&D, manufacturing and distribution) will already apply such controls and compliance measures.
International regulatory agencies have collaborated to produce this guidance.
Intended as a reference for regulated users, including their suppliers, in addition to regulatory inspectors and investigators.
Provides a logical explanation of the basic requirements for the implementation, validation and operation of computerised systems.
May be adapted to identify the criteria for a regulated user, or a regulatory agency, in an inspection of GxP computer systems.
National legislation should to be referred to when determining the extent to which the provisions laid down in this document may be applicable.
This presentation gives a summary of this guidance.
Migrating from Oracle AERS to Argus Safety: Reasons for the MovePerficient, Inc.
Not too long ago, Oracle AERS was the most widely-used adverse event report system. However, with the acquisition of Relsys and its safety and pharmacovigilance system in 2009, Argus Safety quickly became the go-to software for most life sciences companies. Its capabilities and comprehensiveness are unmatched.
Companies currently using Oracle AERS have expressed interest in moving to Argus Safety, but want to know more before making the jump. This webinar is meant to do just that – answer your common questions.
Please join Perficient's Dr. Rodney Lemery, director of safety and pharmacovigilance, as he will:
Compare Argus Safety to AERS
Cover the options of effectively migrating to Argus Safety
CRO/Vendor oversight should support sponsor regulatory requirements and cost containment.Quality Management in clinical operations are Centralized Monitoring, Study Quality Metrics and CRO Oversight.
The PV audit ensures that a company’s drug safety and pharmacovigilance operations comply with applicable laws, regulations and guidances worldwide, and compare to best practices for organizations of similar size.
Using Vault eTMF Milestones and EDLs to Support Inspection ReadinessVeeva Systems
Hear how Daiichi Sankyo is using milestones and expected document lists (EDLs) to enable ongoing inspection readiness and proactive TMF management and oversight.
A session wise PPT for Big Data with knowledge check. The PPT outlines the meaning and purpose of structured, semi-structured, non-structured data. Plus, the PPT discusses about the need and evolution of Big Data as well as its applications. Scope of professional opportunities and skills required are also outlined in the PPT.
Peter Coffee of salesforce.com summarizes the state of the cloud after a decade of enterprise assimilation, and lays out the upside value opportunities of the reconceived Cloud 2 -- combining cloud economy with connected community
Since 2005, when the term “Big Data” was launched, Big Data has become an increasingly topical theme. In terms of technological development and business adoption, the domain of Big Data has made powerful advances; and that is putting it mildly.
In this initial report on Big Data, the first of four, we give answers to questions concerning what exactly Big Data is, where it differs from existing data classification, how the transformative potential of Big Data can be estimated, and what the current situation (2012) is with regard to adoption and planning.
VINT attempts to create clarity in these developments by presenting experiences and visions in perspective: objectively and laced with examples. But not all answers, not by a long way, are readily available. Indeed, more questions will arise – about the roadmap, for example, that you wish to use for Big Data. Or about governance. Or about the way you may have to revamp your organization. About the privacy issues that Big Data raises, such as those involving social analytics. And about the structures that new algorithms and systems will probably bring us.
http://www.ict-books.com/books/inspiration-trends
1Running head BIG DATA6BIG DATAMIT 681 MSIT.docxaulasnilda
1
Running head: BIG DATA
6
BIG DATA
MIT 681 : MSIT capstone
Student name: sunil patel
Student number: 15T1FG68
Professor name: Mark o’connell
Introduction
With the invention of new technology data management has been viewed as one aspect where technology should be implemented. Despite the existence of traditional approaches and methodologies in data storage and management the way data is handled differs from one organization to the other. Big data analysis and storage remains a challenge to many, however much has been achieved and individuals are reaping from the changes which come with new technology techniques such as cloud computing and many other data management technologies (Curry 2016). With individuals having data sources such as the Amazon websites and the yahoo among others proper data storage and accessing tools are very important. It is very important to appreciate the fact that for one to attain high integrity levels in big data management and analysis there are several factors to put into consideration.
These factors include but are not limited to: Flexibility The method of analyzing and storing individual’s data should be able to meet the ever changing technological changes and demands. Maintainability The mechanism should be maintainable by the users Accountability and reliability Users should be able to trust the chosen system and rely on it without fear of losing their data and any other critical information.
The term big data has brought a lot of influences in the data storage, while it is used to refer to a collection of several data from different sources majority are yet to accept the fact that this has been there for ancients with traditional methods applied to access and store the relevant data. Today due to raise in technology security threats have diversified something which calls for users to be alert and practice ethical secure methods when using big data (Gandomi, & Haider 2015). Likewise users need to put into consideration the necessity of the data and ensure they observe the set policies so as to ensure that they do not go against the laid procedures and regulations while using the data. Additionally there are several big data approaches all of which have certain capabilities in managing data.
To be able to succeed in big data approach individuals ought to put into consideration the security concerns and the responses each model offer. Data access, management and storage is a very critical aspect therefore necessary frameworks should be considered before anything. It is very important to establish the programming languages used in the data storage systems; the language extensions and query language since this are key determinants of how successful the chosen approach will be. A clear programming language which is able to accommodate the technological demands remains crucial; the extension languages should also be reliable and manageable. Any storage approach which is not flexible cannot adapt ch ...
BI and big data analytics Force an Overdue Reckoning Between IT and Business ...Dana Gardner
Transcript of a Briefings Direct podcast on the need to solidly align business and IT goals and bring further collaboration on innovation within the enterprise.
The third webcast in this series focuses on ways to meet your health system’s specific needs and achieve a 360-degree view of your patients, processes, physicians, and costs without purchasing multiple, disparate solutions, and creating information silos.
Our speakers discuss their collective experience in working with organizations to create tailored platforms that provide convenient access to data collected by, and stored in, disparate clinical information systems and enabling that data to be securely used by users throughout the broader healthcare community. Actionable data – available to all users when they need it – serves as a foundation for analysis and decision-making aimed at improving how care is delivered.
You can find it online at http://www.informationbuilders.com/webevents/online/24637#sthash.RnwoH27x.dpuf
Sogeti on big data creating clarity - Report 1-4 on Big Data - Sogeti ViNTRick Bouter
Since 2005, when the term “Big Data” was launched, Big Data has become an increasingly topical theme. In terms of technological development and business adoption, the domain of Big Data has made powerful advances; and that is putting it mildly.
In this initial report on Big Data, the first of four, we give answers to questions concerning what exactly Big Data is, where it differs from existing data classification, how the transformative potential of Big Data can be estimated, and what the current situation (2012) is with regard to adoption and planning.
VINT attempts to create clarity in these developments by presenting experiences and visions in perspective: objectively and laced with examples. But not all answers, not by a long way, are readily available. Indeed, more questions will arise – about the roadmap, for example, that you wish to use for Big Data. Or about governance. Or about the way you may have to revamp your organization. About the privacy issues that Big Data raises, such as those involving social analytics. And about the structures that new algorithms and systems will probably bring us.
http://www.ict-books.com/books/inspiration-trends
by Bernard Marr - Big Data is a big thing. It will change our world completely and is not a passing fad that will go away. To understand the phenomenon that is big data, it is often described using five Vs: Volume, Velocity, Variety, Veracity and Value
To implement data-centric security, while simultaneously empowering your business to compete and win in today’s nano-second world, you need to understand your data flows and your business needs from your data. Begin by answering some important questions:
•
What does your organization need from your data in order to extract the maximum business value and gain a competitive advantage?
•
What opportunities might be leveraged by improving the security posture of the data?
•
What risks exist based upon your current security posture? What would the impact of a data breach be on the organization? Be specific!
•
Have you clearly defined which data (both structured and unstructured) residing across your extended enterprise is most important to your business? Where is it?
•
What people, processes and technology are currently employed to protect your business sensitive information?
•
Who in your organization requires access to data and for what specific purposes?
•
What time constraints exist upon the organization that might affect the technical infrastructure?
•
What must you do to comply with the myriad government and industry regulations relevant to your business?
Finally, ask yourself what a successful data-centric protection program should look like in your organization. What’s most appropriate for your organization?
The answers to these and other related questions would provide you with a clearer picture of your enterprise’s “data attack surface,” which in turn will provide you with a well-documented risk profile. By answering these questions and thinking holistically about where your data is, how it’s being used and by whom, you’ll be well positioned to design and implement a robust, business-enabling data-centric protection plan that is tailored to the unique requirements of your organization.
In business, we need to make sure we are ahead of the
curve as this data revolution takes shape. With connected
technology putting our customers firmly in the driving
seat, there are clear challenges which will need to be
overcome.
Collaboration Excellence: Strategies for Enabling a Social BusinessPerficient, Inc.
What goes in to creating exceptional work and web experiences in a social business?
It goes far beyond a simple “build it and they will come” mentality.
Through the use of collaboration tools, enterprises can engage workers, drive innovation, find efficiencies, mobilize workforces, empower leaders and much more.
A strategy for security data analytics - SIRACon 2016Jon Hawes
A snag list for 'things that can go wrong' with big data analytics initiatives in security, and ways to think about the problem space to avoid that happening.
Data is not consistent, sometimes searches or general interest in certain topics, say social media or other types of data experienced peaks and valleys. Data analysis techniques allow the data scientist to mine this type of unstable data and still draw meaningful conclusions from it.
Sharing the story on how connected architecture came into being. The thought process that has led up to a people perspective on data architecture and what it takes to create a sustainable data landscape.
This presentation was given at the Free Frogs customer day in May 2018.
Similar to Designing an EDC System to Work for a CRA (20)
Strategies and Best Practices for Transforming Enterprise TrainingVeeva Systems
Webinar with Carol Benson, associate director of quality systems at Incyte, and Kent Malmros, senior director of Vault Training. They discuss best practices and strategies for successfully transforming learning management systems. There are benefits of starting learning management system selection and implementation with diligent and comprehensive change management approaches.
Topics include:
- Organizational governance strategies for LMS
- How to build on a foundation of GxP compliance
- How to build cross-functional oversight
- Selecting the right learning technologies to eliminate all paper processes
- Best practices for delivering a single system
The Industry’s Move Toward Digitally Connected Clinical TrialsVeeva Systems
The rapid adoption of decentralized trials is causing significant challenges – sites are burdened by too many technologies and the use of multiple patient-facing applications adds complexity for patients.
In these slides, we discuss the implications of decentralized trials, share findings from the Veeva Digital Clinical Trials Survey, and explore how clinical leaders are accelerating digital transformation to make studies more site and patient-centric.
Access the Veeva Digital Clinical Trials Survey Report (https://bit.ly/35eAeDn) for additional insights from more than 280 clinical leaders worldwide on the industry’s progress toward digital trial strategies, lessons learned, and what lies ahead.
Enabling Proactive Quality Management Across Quality and ManufacturingVeeva Systems
Imagine a quality system that allows you to predict and address quality issues before they occur, increase efficiency through intelligent automation, and increase visibility and collaboration across the supply chain.
Today more than 450 pharma, biotech, medtech, and contract services have turned this vision into reality by redesigning their legacy processes and modernizing their quality infrastructure. Using industry best practices and a strong technology foundation, they standardized business processes across GxPs and unified and connected quality and manufacturing systems for speed and efficiency.
In this presentation, you will learn:
- How digital transformation enables companies to pursue quality excellence
- Opportunities to unify and streamline systems and processes
- Best practices from leading companies to enable proactive quality management
Enhance Learning Efficiency in LIfe Sciences with Industry-Leading Learning C...Veeva Systems
See how an end-to-end solution enables customers to modernize training while streamlining resources and improving learning outcomes. Join us to learn how combining best-in-class training content and LMS technology improves efficiency and brings strategic value to your organization.
Join this session to learn:
How adding a standard GxP content library to your LMS increases training efficiency
The best place to start with eLearning content
Scaling your use of a GxP training library based on organizational maturity
Partnering with Veeva for your ongoing learning strategy needs
Moving to unified PV: Transforming Safety with End-to-end PV SolutionsVeeva Systems
New technologies and approaches to safety and pharmacovigilance are enabling end-to-end processes for greater collaboration and oversight.
During Pharmacovigilance World 2021, Jen Markey, VP Vault Safety Strategy Europe, shared how you can leverage a unified PV solution to improve outsourcing, streamline safety, and make compliance easier.
For more information visit:
www.veeva.com/eu/products/vault-safety
Reimagine patient safety 2030 governance through a unified safety platformVeeva Systems
Technology disruptions and healthcare transformation are shifting the roles of QPPV's and senior safety leaders to a more predictive, preventative and participatory safety ecosystem.
During the DIA QPPV Forum, Sharmila Sabaratnam, Senior Director Vault Safety Strategy, shared how you can improve collaboration, benefit-risk data flow and quality and generate insights to maximise patient outcome and minimise avoidable harm through medical governance oversight.
For more information visit:
www.veeva.com/eu/products/vault-safety
Reshaping Global ICSR Reporting to Deliver Real-time Visibility and OversightVeeva Systems
Learn how you can reshape global ICSR reporting to deliver real-time visibility and oversight.
In this presentation we discuss:
- Challenges and approaches to safety data management and ICRS reporting
- How technology is making it easier to comply with global and regional requirements
- Considerations for incorporating affiliates into one pharmacovigilance solution
- Strategies for adopting a single multi-lingual safety solution
View the on-demand webinar here: https://bit.ly/35Pfyik
Tufts Research: EDC Trends, Insights, and OpportunitiesVeeva Systems
Watch the video here: https://bit.ly/3yIrVu0
New Tufts research on the eClinical landscape
Learn how seemingly minor decisions in one functional group can significantly impact overall clinical trial timelines. Specifically, those who never release the database before first patient, first visit (FPFV) take more than three weeks longer to lock the database than those who always release before FPFV. Other key findings include:
* Types and volume of data companies manage in EDC
* The biggest causes of database build delays
* How sponsor and CRO cycle times compare for database build, data entry, and database lock
Who Will Benefit:
* Data Management
* eClinical
* Clinical Operations
* Biometrics
* Clinical Development
* R&D IT
Tufts Research: Strategies from Data Management Leaders to Speed Clinical TrialsVeeva Systems
Watch the video here: https://bit.ly/3wChmGQ
Learn how top pharmas and CROs plan to speed database build and data collection, as well as their top challenges and future priorities. In this webinar you'll gain insights into:
* Taking an agile approach to database build
* Reducing UAT timelines with a risk-based approach
* Driving innovation at your organization
This in-depth research from Tufts follows their industry-wide eClinical Landscape Study, examining the major cause of database build delays and their impact on trial cycle times.
Meet Your Presenters:
Ken Getz
Director of Sponsored Programs, Tufts CSDD
Richard Young
Vice President, Vault EDC, Veeva Systems
Webinar: Rethinking the Life Sciences Training Technology EcosystemVeeva Systems
Watch the full webinar here: https://go.veeva.com/training-ecosystem-2021
As a training steward, you are required to select the right systems to enable an effective and efficient training program for your organization. But the task is easier said than done due to an increasingly complex technology landscape.
Join Kent Malmros, Sr. Director of Veeva Vault Training, to learn about different training technologies available today and how they fit together to create an optimal learning environment for both administrators and learners. You will also learn about technologies you won't need, reducing the cost and complexity of your training environment.
In this one hour webinar, you will learn:
Key definitions and descriptions of modern training technology categories
How to prioritize acquiring new job technologies and eliminating legacy solutions
Best practices for effectively connecting systems and processes to ensure faster time to qualification and competency
We will also have a deep dive discussion into:
Authoring tools
Document and Content Management Systems
Learning Management Systems
Gamification Frameworks
Learning Experience Platforms
Validation strategies for cloud-based EDCs: more innovation, less effortVeeva Systems
Watch the video here: https://bit.ly/2SxsAxO
Validation concerns can hold companies back from adopting innovations in their clinical systems
Validation concerns can hold companies back from adopting the latest innovations in their EDC systems. Differing opinions on the appropriate level of system validation can also add stress within an organization. It is possible to implement new features and stay validated with relatively little effort if you use validation techniques tailored to cloud-based systems.
In this session, we address how to set the right approach, what to expect from a cloud EDC software provider and what you should expect to do as a sponsor or CRO to perform the initial validation and maintain a validated state following subsequent releases.
Who Will Benefit:
* Clinical Data Manager
* Clinical Data Director
* Head of Clinical Data
* Clinical Operations Manager
* Clinical Operations Director
* Data management
* Biostatistics
* Data science
* Clinical science
* EDC
* Biometrics
* eClinical
Meet Your Presenters:
Natalie Townsend
Senior Solution Consultant, Vault CDMS
As Senior Solution Consultant for Vault CDMS Natalie is responsible for understanding customer challenges and objectives and providing technical product demonstrations tailored to address these needs. Natalie has 16+ years industry experience in designing, implementing and supporting eClinical solutions to address the myriad of challenges faced across biopharmaceutical organizations. Her experience with clinical trials spans a broad range of sponsors and therapeutic areas across all phases and regions, allowing her to appreciate the differing technology considerations and needs.
Tanya du Plessis
Vice President of data strategies and solutions, Bioforum the Data Masters
Tanya is Vice President of data strategies and solutions at Bioforum. She has vast experience across the industry through her current role at Bioforum, as well as the 14 years she spent with IQVIA (legacy Quintiles). Throughout her career, Tanya has worked with multinational pharmaceutical companies as well as small-to-mid size biotechs and startups. She has led various data management operations and programs, heading numerous innovation teams and spearheading the development of strategies for customized data delivery solutions, focusing on timely, quality data. A certified clinical data manager (CCDM, SCDM), Tanya holds a M.Med.Sc in Hematology and Cell Biology from University of the Free State in South Africa. She also has a project management professional certification (PMP, PMI).
Vertex Reduces EDC Study Build Times by 50%Veeva Systems
Watch the video here: https://bit.ly/3oUi6Vg
The clinical data team at Vertex asked themselves, how can we reduce our development timelines and costs—make things go faster, for less?
Answering those questions set Vertex on a path to challenge themselves and their vendors to improve speed without sacrificing quality. As a result, they’re reducing database build times by as much as 50% and reliably lock data in 15-18 days.
This webinar covers:
* How Vertex reaches 80-90% compliance with sites entering data within 2 days of the event
* Their #1 goal for transforming the UAT process
* Their novel recommendation for when to go live
* The technology strategy supporting their process improvements
Who Will Benefit:
* Clinical data executives
* Heads of clinical
* Heads of clinical research
Meet Your Presenters:
Vikas Gulati
Senior Director of Clinical Data Management and Metrics, Vertex Pharmaceuticals
Vikas Gulati has over 20 years’ experience focused on clinical data management, data standards and governance. He has led several global cross-functional teams to successful outcomes in Biotech/Pharma and CROs. He is currently the Global Head of Clinical Data Management at Vertex Pharmaceuticals, Inc.
Richard Young
Vice President, Vault EDC, Veeva Systems
Richard Young has nearly 25 years of expertise in data management, clinical solutions, and advanced clinical strategies. At Veeva, Young is establishing Vault EDC as the leading solution for clinical data management.
Michelle Harrison
Associate Director of Clinical Data Management and Metrics, Vertex
Michelle Harrison is currently working at Vertex Pharmaceutical in Boston Massachusetts as an Associate Director of Data Management. Prior to joining Vertex, she worked as a consultant for BioBridges. For 2 years there she consulted for a number of small Biotechs assisting with Vendor oversight and start up activities.
How ICON, Lotus, and Bioforum are Improving Study Efficiency with a Modern EDCVeeva Systems
Watch the video here: https://bit.ly/3urhVSi
CROs are often at the forefront of adopting new technologies to make clinical trials more efficient. Hear how ICON, Lotus Clinical Research, and Bioforum are speeding database builds and automating reporting tasks for data management. They’ll share insights into how to:
* Build a database from standards and your protocol (not a spec)
* Replace manual documentation with system-generated reports
* Provide real-time visibility into the status of data collection and cleaning
Hear their first-hand accounts of adopting an Agile Design methodology with Veeva Vault CDMS and reaping the rewards of a straightforward build and a modern EDC.
PICI’s Best Practices for Building Oncology Studies in an EDCVeeva Systems
Watch the video here: https://bit.ly/3vrYslR
The Parker Institute for Cancer Immunotherapy (PICI) runs complex clinical trials that depend on an electronic data capture (EDC) system that is adaptive, flexible and innovating at the same pace as their patient-centric mission.
Learn why their legacy EDC system workarounds and custom functions no longer sustained their business, which motivated them to take a new approach. In this webinar, Toby Odenheim, the Director of Technology and Governance, will share how PICI decided to adopt a new EDC system that streamlines the build process for oncology trials and how they better equip their clinical programmers and data managers. PICI’s lead study builder, Gary Smith, will provide a hands-on perspective and share strategies to handle the key challenges that oncology teams face with EDC systems, including:
* Umbrella trials that evaluate multiple therapies
* Adaptive trial branching and routing
* Having an unknown number of treatment cycles
* Amendments and other unplanned changes
Who Will Benefit:
* Data managers
* Database Programmers
* Clinical Programmers
* Clinical programmers in charge of building studies
* Clinical leaders in charge of selecting EDC systems
* EDC Programmers
Meet Your Presenters:
Toby Odenheim
Director, Technology and Governance, Parker Institute for Cancer Immunotherapy
In his current role as director of technology and governance at PICI, Toby Odenheim, MBA, leads an array of technology and process improvement initiatives aimed at accelerating the development of innovative cancer immunotherapy treatments. Core areas of oversight include management of clinical and pharmacovigilance systems, including CTMS, eTMF, IRT, EDC, ePRO, medical coding, safety, and business intelligence systems.
Prior to joining PICI, Odenheim was the founder and principal at Odin Life Sciences Consulting, where he guided companies in the selection, implementation, and validation of best-of-breed clinical technologies. Toby Odenheim has held management positions at Gilead, Synteract, ClinicalSoft, and Pfizer. He holds an undergraduate degree in biology, an MBA, and professional certifications in finance, Oracle database administration, and relational database design.
Gary Smith
Senior EDC Programmer/Analyst, Parker Institute for Cancer Immunotherapy
Gary has over twenty years of experience in clinical programming and is a subject matter expert on study design, configuration, and testing with off-the-shelf EDC systems including Veeva Vault CDMS, Medidata Rave, and Oracle Clinical. Gary has deep expertise in building oncology studies, specifically platform studies, and is currently responsible for all aspects of EDC design and study builds in immuno-oncology studies with the Parker Institute for Cancer Immunotherapy. Gary has developed global libraries for five different companies, spanning medical device and pharmaceutical industries.
The Benefits of a Seamless IRT and EDC Integration in Clinical Trial ExecutionVeeva Systems
Watch the video here: https://bit.ly/3upehbN
Veeva and Suvoda have combined their offerings into a powerful streamlined integration, which accommodates advanced study designs while driving down build and casebook complexity.
Hear Catherine Munera, head of biometrics at Cara Therapeutics, share the benefits of moving from a single provider to taking a harmonized, best-of-breed approach with IRT and EDC.
Unify quality manufacturing to drive speed, compliance and collaborationVeeva Systems
Whether you are an emerging CDMO looking to scale and attract sponsors or an established generics org looking to transform legacy systems, there is an approach to consider! Learn how you can drive efficiency, collaboration, and compliance and how to get started in unifying your quality manufacturing processes.
Shorten Database Builds by 60% with Agile DesignVeeva Systems
Watch the video here: https://bit.ly/3f64wJZ
See the Packed #SCDM2019 Session
Radical time savings aren’t possible with incremental process improvements. An agile EDC enables process transformation that shortens database builds by 40-60%. Join a live webinar of the packed SCDM product showcase to hear the technologies and processes behind those savings, including real-time UAT, data-driven rules and dynamics, and easy amendments.
Best practices for implementing and maintaining successful standardsVeeva Systems
Watch the video here: https://bit.ly/3uvar1u
This webinar provides best practices, check-lists and case studies for leveraging standards in clinical trials. From creation and implementation, to governance tools (both internal and with external partners), attendees walk away with actionable insights to leverage with their own organization.
* Understand what to standardize
* Learn several approaches to standards development and when they make sense
* Ensure alignment with key stakeholders
* Maintain and govern standards over time
* Reduce overall configuration time
Who Will Benefit:
* Clinical Data (manager/director/head of) Clinical ops
* Data management
* Biostatistics
* Data science
* Clinical science
* EDC
* Biometrics
* eClinical
* Data standards
* Quantitative sciences
* Informatics
* Data monitoring
* Clinical leads
* Study managers
* Clinical study
* Data manager
* CRA
* CDISC
Meet Your Presenters:
Carla Reis
Director, Client Services, 4G Clinical
Carla Reis, Director of Client Services at 4G Clinical, has over 18 years of experience as an operational leader in developing and implementing RTSM systems in a global pharmaceutical company. Carla was a leader in her organization in establishing vendor management standards and processes. She has helped lead major RTSM process improvement initiatives where she established new and innovated approaches to drug assignment verification and vendor integrations. Carla has presented at industry conferences as a subject matter expert on best practices using RTSM solutions for complex strategies in supply chain management. Carla holds a BS in Neurobiology and Physiology from the University of Connecticut and a certification as Lean Six Sigma Yellow Belt. Carla also holds a Masters in Science in Health Administration with a concentration in Health Informatics from Saint Joseph's University.
Paul MacDonald
Senior Director, Strategy Vault CDMS, Veeva Systems
Paul is Senior Director Vault CDMS, responsible for strategy and direction in data management. With 25+ years experience working in life science at pharma, CRO and technology organisations, Paul brings a strong operational focus in relation to eClinical technology for data management and clinical operations that stretches from EDC, through CTMS to risk based monitoring.
Veeva Systems Webinar: Driving Continuous Quality ImprovementsVeeva Systems
Watch the on-demand webinar here: https://go.veeva.com/driving-continuous-quality-improvements/on-demand
Building a strong foundation to drive continuous quality improvements requires connecting people, processes, and technology. Life sciences companies transforming quality management with this holistic approach have increased quality management efficiency by up to 50% and reduced paperwork by 90%.
Watch the webinar and learn how you can create such a foundation for your organization on an intelligent, data-driven, end-to-end digital platform. You will also hear real-world use cases of applying advanced technologies like AI to enable proactive quality management across all operational areas.
You will hear:
- Opportunities and recommendations to unify and streamline quality systems and processes
- Areas where modern-era technologies like cloud and AI can increase efficiency, optimize cost, and bring products to patients faster
- Real-world examples of how leading organizations are transforming quality management to drive continuous quality improvements.
Building a Foundation for Proactive and Predictive PharmacovigilanceVeeva Systems
Learn how PV teams can easily keep up with evolving compliance requirements with modern safety applications that provide better data control and drive greater efficiencies.
View on-demand session: https://bit.ly/3vIzQG9
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!